SNOQUALMIE, Wash.–(BUSINESS WIRE)–Spacelabs Healthcare (the “Company” or “Spacelabs”), a division of OSI Systems, Inc. (“OSI Systems”) (NASDAQ: OSIS), today announced the release of Lifescreen™ Pro event screening system. Lifescreen Pro expands the Company’s non-invasive cardiology offerings, which include Spacelabs Pathfinder SL ambulatory ECG analysis system. Building on 40 years of technology, design, algorithm development and experience in the analysis of ambulatory ECG recordings, the release of Lifescreen Pro continues Spacelabs’ mission to diagnose cardiac arrhythmias accurately and economically.

“Health monitoring today is much more than a collection of vital signs,” said Spacelabs President Shalabh Chandra. “Cardiologists need rapid and actionable data analysis to ensure their patients are on the right care path, without delay. With Lifescreen Pro, they have a powerful new tool to deliver faster, enhanced care.”

Event screening allows cardiologists, electrophysiologists, and hypertension specialists to quickly differentiate benign recordings from those requiring a more comprehensive analysis of ECG morphologies. Lifescreen Pro provides rapid analysis, allowing an initial triage to find suspected or intermittent arrhythmia events. The entire recording or specific areas of focus can be seamlessly passed from Lifescreen Pro into Pathfinder SL for a comprehensive exploration of a patient’s cardiac condition without the need for a second recording.

With local access to Lifescreen Pro, specialists no longer need to wait for an external service to process diagnostic tests and return the reports, and results can be made securely available wherever needed using Spacelabs’ Sentinel cardiology information management system. Patients also benefit as they can often review a comprehensive report with their provider without the need for a second visit. This allows patients to continue their care pathway as soon as possible.